Search - tctmd.com

Displaying 101 - 117 of 117

Sort: Relevancy | Date

News Daily News

Rising Subdural Hematoma Rates Appear to Be Linked to Greater Use of Antithrombotics

Todd Neale

March 03, 2017

Triple Antiplatelet Therapy Does Not Reduce Recurrent Events in Patients With Acute Ischemic Stroke or TIA

News Conference News ISC 2017

Triple Antiplatelet Therapy Does Not Cut New Events in Acute Ischemic Stroke or TIA

Todd Neale

February 23, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Conference News CRT 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Michael O'Riordan

February 20, 2017

News Daily News

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Michael O'Riordan

February 13, 2017

Presentation JIM 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presenter: Roxana Mehran

February 10, 2017

News Daily News

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

Todd Neale

February 08, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Conference News ISET 2017

Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not?

Caitlin E. Cox

February 06, 2017

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Daily News

Noncardiac Surgery Riskier After Incomplete vs Complete Revascularization, Observational Study Finds

Yael L. Maxwell

February 01, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Advertisement

Rising Subdural Hematoma Rates Appear to Be Linked to Greater Use of Antithrombotics

Triple Antiplatelet Therapy Does Not Cut New Events in Acute Ischemic Stroke or TIA

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not?

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Noncardiac Surgery Riskier After Incomplete vs Complete Revascularization, Observational Study Finds

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Changing Course with Anticoagulation in Secondary Prevention of CAD

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content